Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-391167
Filing Date
2014-10-31
Accepted
2014-10-31 10:12:14
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d802341d10q.htm 10-Q 492283
2 EX-31.1 d802341dex311.htm EX-31.1 5807
3 EX-31.2 d802341dex312.htm EX-31.2 6068
4 EX-32.1 d802341dex321.htm EX-32.1 3261
5 EX-32.2 d802341dex322.htm EX-32.2 3535
  Complete submission text file 0001193125-14-391167.txt   4157485

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cbrx-20140930.xml EX-101.INS 539966
7 XBRL TAXONOMY EXTENSION SCHEMA cbrx-20140930.xsd EX-101.SCH 44892
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbrx-20140930_cal.xml EX-101.CAL 80264
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbrx-20140930_def.xml EX-101.DEF 110477
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbrx-20140930_lab.xml EX-101.LAB 341813
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbrx-20140930_pre.xml EX-101.PRE 241692
Mailing Address 4 LIBERTY SQUARE 4TH FLOOR BOSTON MA 02109
Business Address 4 LIBERTY SQUARE 4TH FLOOR BOSTON MA 02109 973-486-8820
COLUMBIA LABORATORIES INC (Filer) CIK: 0000821995 (see all company filings)

EIN.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10352 | Film No.: 141185151
SIC: 2834 Pharmaceutical Preparations